Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MMP3 | P08254 | 4/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MMP13 | P45452 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1285747 | 0.95 | MMP2 (0.85) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL4614541 | 0.95 | MMP2 (0.73) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL5516422 | 0.93 | MMP2 (0.71) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL3952240 | 0.93 | MMP2 (0.71) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL1139009 | 0.93 | MMP2 (0.71) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL926790 | 0.91 | MMP2 (0.90) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL7718574 | 0.91 | MMP2 (0.64) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL7718572 | 0.91 | MMP2 (0.64) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL4273348 | 0.90 | MMP2 (0.82) | MMP2ALDH1A1MAPTMMP3MMP1 | |
| SCHEMBL9128810 | 0.89 | MMP2 (0.80) | MMP2ALDH1A1MAPTMMP3MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040067576-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2004-04-08 | — | — | US | claimed |
| US-20030208029-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | claimed |
| US-20020022253-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2002-02-21 | — | — | US | claimed |
| EP-1113033-A2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2001-07-04 | — | — | EP | claimed |
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| EP-1113033-B1 | Polyhydroxyalkanoate | CANON KK (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
| US-7169598-B2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2007-01-30 | — | — | US | disclosed |
| US-7169598-B2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20040067576-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6649381-B1 | Biosynthesis of high purity polylactones | CANON KABUSHIKI KAISHA (JP) | 2003-11-18 | — | — | US | disclosed |
| US-20030208029-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | disclosed |
| US-6586562-B2 | Polylactone with units such as of 3-hydroxy-5-(4-fluorophenyl)valeric acid; biosynthesis of the polylactone by microorganism; Pseudomonas cichorii; P. putida; P. jessenii | CANON KABUSHIKI KAISHA (JP) | 2003-07-01 | — | — | US | disclosed |
| US-20020022253-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2002-02-21 | — | — | US | disclosed |
| EP-1113033-A2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2001-07-04 | — | — | EP | disclosed |
| US-5574016-A | Peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | disclosed |
| EP-0513675-B1 | New peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-09-11 | — | — | EP | disclosed |
| EP-0513675-A1 | New peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| US-4086240-A | 1-Thiazolyl-5-phenoxy and phenylthioalkanoyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1978-04-25 | — | — | US | disclosed |
| US-4053480-A | 1-THIADIAZOLYL-5-PHENOXY- AND PHENYLTHIOALKANOYLOXY IMIDAZOLIDINONES | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | MMP2 3541/4885ALDH1A1 1819/4885MAPT 763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.